Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Sees Significant Decrease in Short Interest

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the recipient of a significant decrease in short interest in June. As of June 15th, there was short interest totalling 669,200 shares, a decrease of 67.2% from the May 31st total of 2,041,900 shares. Based on an average daily volume of 18,200 shares, the short-interest ratio is currently 36.8 days.

Shanghai Fosun Pharmaceutical (Group) Trading Down 1.6 %

OTCMKTS:SFOSF traded down $0.03 during trading hours on Thursday, reaching $1.67. The company’s stock had a trading volume of 4,585 shares, compared to its average volume of 9,466. Shanghai Fosun Pharmaceutical has a one year low of $1.52 and a one year high of $2.72. The business’s 50-day moving average is $1.60 and its 200-day moving average is $1.77.

Shanghai Fosun Pharmaceutical (Group) Company Profile

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments.